Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy Based on the Resistance Profile, in Children, Adolescents and Adults With Virological Failure of Their HIV Therapy, in Three HIV Clinics in Tanzania

NCT03557021 is registered in ClinicalTrials.gov with Medical Mission Institute, Germany as lead sponsor.

NCT NCT03557021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03557021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy Based on the Resistance Profile, in Children, Adolescents and Adults With Virological Failure of Their HIV Therapy, in Three HIV Clinics in Tanzania
Lead sponsor
Medical Mission Institute, Germany
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2017
Completion date
September 30, 2020
Enrollment
1,250 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv drug resistance